FDA Adds Liver Warning to Thyroid Drug
On June 3, 2009, the FDA advised physicians of the possible risk of serious liver injury with propylthiouracil, a drug prescribed to treat overactive thyroid glands or Graves' disease.
Propylthiouracil is considered second-line treatment but is used when patients can't take another drug, methimazole. The FDA said it saw an increased ...